Karine Lugardon

761 total citations
12 papers, 651 citations indexed

About

Karine Lugardon is a scholar working on Microbiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Karine Lugardon has authored 12 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Microbiology, 7 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Karine Lugardon's work include Antimicrobial Peptides and Activities (8 papers), Biochemical and Structural Characterization (4 papers) and Neuropeptides and Animal Physiology (4 papers). Karine Lugardon is often cited by papers focused on Antimicrobial Peptides and Activities (8 papers), Biochemical and Structural Characterization (4 papers) and Neuropeptides and Animal Physiology (4 papers). Karine Lugardon collaborates with scholars based in France, Germany and Norway. Karine Lugardon's co-authors include Dominique Aunis, Yannick Goumon, Marie‐Hélène Metz‐Boutigue, Jean‐Marc Strub, Bruno Kieffer, Alain Van Dorsselaer, Angelo Corti, Philippe Bulet, Agnès F. Delmas and Marc Moniatte and has published in prestigious journals such as Journal of Biological Chemistry, Annals of the New York Academy of Sciences and PROTEOMICS.

In The Last Decade

Karine Lugardon

12 papers receiving 634 citations

Peers

Karine Lugardon
Murray R. Robinovitch United States
J.L. Dutton Australia
Susana A. Serrate United States
Kin Ki Jim Netherlands
Murray R. Robinovitch United States
Karine Lugardon
Citations per year, relative to Karine Lugardon Karine Lugardon (= 1×) peers Murray R. Robinovitch

Countries citing papers authored by Karine Lugardon

Since Specialization
Citations

This map shows the geographic impact of Karine Lugardon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karine Lugardon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karine Lugardon more than expected).

Fields of papers citing papers by Karine Lugardon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karine Lugardon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karine Lugardon. The network helps show where Karine Lugardon may publish in the future.

Co-authorship network of co-authors of Karine Lugardon

This figure shows the co-authorship network connecting the top 25 collaborators of Karine Lugardon. A scholar is included among the top collaborators of Karine Lugardon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karine Lugardon. Karine Lugardon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Zoulim, Fabien, François Habersetzer, Martin F. Sprinzl, et al.. (2019). Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial. Human Vaccines & Immunotherapeutics. 16(2). 388–399. 66 indexed citations
2.
Metz‐Boutigue, Marie‐Hélène, et al.. (2005). Antibacterial and Antifungal Peptides Derived from Chromogranins and Proenkephalin-A. Kluwer Academic Publishers eBooks. 482. 299–315. 7 indexed citations
3.
Brekke, Johan Fredrik, Jorunn Kirkeleit, Karine Lugardon, & Karen B. Helle. (2005). Vasostatins. Kluwer Academic Publishers eBooks. 482. 239–246. 9 indexed citations
4.
5.
Metz-Boutigue, M.-H., Yannick Goumon, Jean‐Marc Strub, Karine Lugardon, & Dominique Aunis. (2003). Antimicrobial Chromogranins and Proenkephalin‐A—Derived Peptides. Annals of the New York Academy of Sciences. 992(1). 168–178. 34 indexed citations
6.
Lugardon, Karine, Sylvette Chasserot‐Golaz, Régine Maget‐Dana, et al.. (2002). Structural and Biological Characterization of Chromofungin, the Antifungal Chromogranin A (47‐66)‐Derived Peptide. Annals of the New York Academy of Sciences. 971(1). 359–361. 13 indexed citations
7.
Lugardon, Karine, Sylvette Chasserot‐Golaz, Régine Maget‐Dana, et al.. (2001). Structural and Biological Characterization of Chromofungin, the Antifungal Chromogranin A-(47–66)-derived Peptide. Journal of Biological Chemistry. 276(38). 35875–35882. 86 indexed citations
8.
Goumon, Yannick, Karine Lugardon, Jean‐Marc Strub, et al.. (2000). Processing of Proenkephalin-A in Bovine Chromaffin Cells. Journal of Biological Chemistry. 275(49). 38355–38362. 29 indexed citations
9.
Lugardon, Karine, Yannick Goumon, Angelo Corti, et al.. (2000). Antibacterial and Antifungal Activities of Vasostatin-1, the N-terminal Fragment of Chromogranin A. Journal of Biological Chemistry. 275(15). 10745–10753. 146 indexed citations
10.
Goumon, Yannick, et al.. (1998). Antibacterial Peptides Are Present in Chromaffin Cell Secretory Granules. Cellular and Molecular Neurobiology. 18(2). 249–266. 80 indexed citations
11.
Goumon, Yannick, Karine Lugardon, Bruno Kieffer, et al.. (1998). Characterization of Antibacterial COOH-terminal Proenkephalin-A-derived Peptides (PEAP) in Infectious Fluids. Journal of Biological Chemistry. 273(45). 29847–29856. 57 indexed citations
12.
Strub, Jean‐Marc, Yannick Goumon, Karine Lugardon, et al.. (1996). Antibacterial Activity of Glycosylated and Phosphorylated Chromogranin A-derived Peptide 173-194 from Bovine Adrenal Medullary Chromaffin Granules. Journal of Biological Chemistry. 271(45). 28533–28540. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026